Inactive Instrument

BLIRT S.A. Stock

Equities

BLR

PLBLIRT00018

Dynamic Chart
BLIRT S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Qiagen N.V. completed the acquisition of 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian Popinigis and others for $64 million. CI
Sector Update: Health Care Stocks Edging Lower Ahead of Wednesday Close MT
Sector Update: Health Care Stocks Still Hanging on for Small Advance MT
Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum MT
Qiagen N.V. agreed to acquire 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian Popinigis and others. CI
BLIRT S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021 CI
BLIRT S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
BLIRT S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
BLIRT S.A. Announces Earnings Results for the Second Quarter Ended June 30, 2021 CI
Blirt S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
BLIRT S.A. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Agencja Rozwoju Pomorza S.A. cancelled the acquisition of the remaining 76.91% stake in Transmedium Tadeusz Macha from BLIRT S.A.. CI
Agencja Rozwoju Pomorza S.A. signed a share purchase agreement to acquire the remaining 76.91% stake in Transmedium Tadeusz Macha from BLIRT S.A. for approximately PLN 160 million. CI
BLIRT S.A. announced that it has received PLN 0.84 million in funding from N50 Cyprus Limited CI
More news
Managers TitleAgeSince
Chief Executive Officer 60 -
Chief Tech/Sci/R&D Officer - -
Director/Board Member 39 -
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Chairman - -
More insiders
Blirt SA is a Poland-based company, which is involved in the production of specialized enzymes and reagents dedicated to use in Life Science. The Company develops protein production methods (upstream and downstream) and conducting production on an industrial scale. Other product groups in which entity is specializing are kits for nucleic acid isolation, reverse transcription reagents and Real-Time PCR.
Sector
-
More about the company